|Year : 2017 | Volume
| Issue : 2 | Page : 208-213
Clinical efficacy of a combination of Percoll continuous density gradient and swim-up techniques for semen processing in HIV-1 serodiscordant couples
Osamu Inoue1, Naoaki Kuji2, Hiroe Ito2, Mitsutoshi Yamada1, Toshio Hamatani1, Aimi Oyadomari3, Shingo Kato3, Hideji Hanabusa4, Keiichi Isaka2, Mamoru Tanaka1
1 Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo 1608582, Japan
2 Department of Obstetrics and Gynecology, Tokyo Medical College, Tokyo 1600023, Japan
3 Department of Microbiology, Keio University School of Medicine, Tokyo 1608582, Japan
4 Department of Hematology, Ogikubo Hospital, Tokyo 1670035, Japan
|Date of Submission||17-May-2015|
|Date of Decision||31-Jul-2015|
|Date of Acceptance||07-Dec-2015|
|Date of Web Publication||23-Feb-2016|
Prof. Naoaki Kuji
Department of Obstetrics and Gynecology, Tokyo Medical College, Tokyo 1600023, Japan
Source of Support: None, Conflict of Interest: None
To evaluate the clinical efficacy of a procedure comprising a combination of Percoll continuous density gradient and modified swim-up techniques for the removal of human immunodeficiency virus type 1 (HIV-1) from the semen of HIV-1 infected males, a total of 129 couples with an HIV-1 positive male partner and an HIV-1 negative female partner (serodiscordant couples) who were treated at Keio University Hospital between January 2002 and April 2012 were examined. A total of 183 ejaculates from 129 HIV-1 infected males were processed. After swim-up, we successfully collected motile sperms at a recovery rate as high as 100.0% in cases of normozoospermia (126/126 ejaculates), oligozoospermia (6/6), and asthenozoospermia (36/36). The recovery rate of oligoasthenozoospermia was 86.7% (13/15). In processed semen only four ejaculates (4/181:2.2%) showed viral nucleotide sequences consistent with those in the blood of the infected males. After using these sperms, no horizontal infections of the female patients and no vertical infections of the newborns were observed. Furthermore, no obvious adverse effects were observed in the offspring. This protocol allowed us to collect HIV-1 negative motile sperms at a high rate, even in male factor cases. We concluded that our protocol is clinically effective both for decreasing HIV-1 infections and for yielding a healthy child.
Keywords: assisted reproductive technology; human immunodeficiency virus type 1; serodiscordant couple; viral nucleotide sequence
|How to cite this article:|
Inoue O, Kuji N, Ito H, Yamada M, Hamatani T, Oyadomari A, Kato S, Hanabusa H, Isaka K, Tanaka M. Clinical efficacy of a combination of Percoll continuous density gradient and swim-up techniques for semen processing in HIV-1 serodiscordant couples. Asian J Androl 2017;19:208-13
|How to cite this URL:|
Inoue O, Kuji N, Ito H, Yamada M, Hamatani T, Oyadomari A, Kato S, Hanabusa H, Isaka K, Tanaka M. Clinical efficacy of a combination of Percoll continuous density gradient and swim-up techniques for semen processing in HIV-1 serodiscordant couples. Asian J Androl [serial online] 2017 [cited 2019 Apr 22];19:208-13. Available from: http://www.ajandrology.com/text.asp?2017/19/2/208/173442 - DOI: 10.4103/1008-682X.173442
| Introduction|| |
Currently, around 33 million people are reportedly infected with the human immunodeficiency virus type 1 (HIV-1) worldwide, and 80% of these people belong to the reproductive age group. Since the introduction of highly active antiretroviral therapy (HAART) in 1996, HAART use by the infected person was accompanied by a 92% reduction in risk of HIV-1 transmission to their partner. Although sexual contact serves as the major transmission route for HIV, it has been reported that HIV can also be transmitted by artificial insemination,, indicating that the infection can be spread horizontally from infected sperm. Because of its high prevalence among youth, preventing secondary infection in couples consisting of an HIV-1-positive male partner and an HIV-1 negative female partner (serodiscordant couples) is important.
Because HIV-1 in sperm can be removed by processing semen, current therapeutic approaches for infertility, including intrauterine insemination (IUI) and in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI), now involve semen processing to reduce the risk of horizontal and vertical infection. However, Garrido et al. reported 10% of the samples positive by nested polymerase chain reaction (nested-PCR). We have developed a sperm recovery method that combines Percoll continuous density gradient and modified swim-up techniques. We investigated the clinical efficacy of this processing technique in terms of sperm recovery, HIV-1 detection in the washed sperm suspensions and embryo culture media, and pregnancy outcomes.
| Materials and Methods|| |
We performed assisted reproductive technology (ART) for 129 HIV-1 serodiscordant couples treated at Keio University Hospital between January 2002 and April 2012. Because of the decrease in the ovarian reserve, couples in which the female was 42 years of age or older were excluded. Cases with azoospermia in the ejaculate were also excluded. Some patients had complicating infections, including hepatitis B, hepatitis C, and/or syphilis. Many patients in this study were hemophiliacs, who were to become infected with HIV-1 through repeated infusions of plasma-derived products. Before starting the treatment, women partners were confirmed as being HIV-1 seronegative at the initial diagnosis based on antibody screening using an HIV-enzyme linked immunosorbent assay (HIV-ELISA). All the participating couples provided their written informed consent after receiving a thorough explanation of the risk of HIV-1 infection and the risks and benefits of IVF and ICSI. This study was approved by the Institutional Review Board of Keio University.
Semen collection, processing, and freezing
After approximately 3-5 days of abstinence, semen samples were collected. In accordance with the World Health Organization (WHO) laboratory manual for the Examination and Processing of Human Semen (5th Edition), semen analysis was begun after the sample liquefied, usually within 15-60 min at room temperature. The specimens were divided into two aliquots. For both aliquots, HIV-1 was removed through our Percoll continuous density gradient and modified swim-up method.
The semen processing protocol has been described elsewhere. Briefly, to prepare the Percoll continuous density gradient, 2 ml of Percoll (80%) was overlaid with 2 ml of Hanks balanced salt solution in a sterilized disposable centrifuge tube (Round tube, #2059, Falcon) and the tube was rotated to maintain a 76° vertical tilt. The semen from the infected male was diluted by adding 1 ml of Hanks solution, then overlaid on the prepared continuous gradient before centrifugation at 1600 ×g for 10 min. After centrifugation, a sterilized thumbtack with a silicone protector was used to punch a small hole at the bottom of the tube, and an aliquot of medium containing motile sperm was recovered through this hole, washed once with culture medium, then re-suspended in 0.3 ml quantities.
To introduce the sperm suspension to the bottom of the swim-up tube without allowing it to come in contact with the HIV-1-free medium of the upper layer, outer and inner embryo transfer (ET) tubes were utilized ([Figure 1]). First, the outer sheath of the ET tube was set near the bottom of the centrifuge tube in the Percoll continuous density gradient ( a ). Second, the inner ET tube was introduced inside the outer sheath ( b1 ). The sperm suspension prepared by density gradient centrifugation was loaded into the inner tube, which was then placed beneath the medium ( c2 and c3 ) so that the potentially contaminated inner tube would not come directly in contact with the culture medium. After 45 min, the swim-up sperm (0.5 ml) was recovered from the surface of the medium ( d4 ). Each resultant sperm suspension was then divided into two portions: one portion was used for the detection of HIV-1 using nested-PCR targeted at the gag genes, and the other was frozen for future use in ART. Cryopreservation of the sperm suspension was performed using liquid nitrogen vapor with KS-II cryo-medium.
|Figure 1: Preparation of the swim-up apparatus using an embryo transfer tube. (a) First, the outer sheath of the ET tube was set near the bottom of the centrifuge tube in the Percoll continuous density gradient. (b1) Thereafter, the inner ET tube was introduced inside the outer sheath. (c2 and c3) The sperm suspension prepared by density gradient centrifugation was loaded in the inner tube, which was then placed beneath the medium so that the potentially contaminated inner tube would not come in direct contact with the culture medium. (d4) After 45 min, the swim-up sperm was recovered from the surface of the medium. ET: embryo transfer.|
Click here to view
To prevent the processed HIV-1 containers from contaminating other semen samples, they were stored using standard cryopreservation in a storage tank with liquid nitrogen vapor for 1 or 2 months until the results of the nested-PCR analysis were ascertained. After confirming that the semen sample was HIV-1 negative, it was transferred to a liquid nitrogen container for subsequent ICSI.
To reduce bias, we attempted to use the same methods for semen processing and swim-up in all the cases, regardless of the semen parameters, blood viral load, or history of HAART. In addition, HIV-1 testing was performed using the same protocol for all the subjects in this series. The viral load in unprocessed semen was not measured.
Assisted reproductive technology
Ovarian stimulation was conducted using either the gonadotropin-releasing hormone (GnRH) agonist Buserelin (Suprecur®: Mochida Pharmaceutical) long protocol or the GnRH antagonist cetrorelix/ganirelix (Cetrotide®: Shionogi, Ganirest®: MSD) protocol, depending on the age and hormonal status of the female patient, as well as recombinant follicle stimulation hormone (FSH) (Follistim®: Schering-Plough Corporation, Gonal F®: Serono Pharmaceutical) or human menopausal gonadotrophin (HMG) (Ferring®: Ferring Pharma, HMG Teizo®: Aska Pharmaceutical). The administration of a GnRH agonist was started during the midluteal phase of the previous cycle, and the administration of a GnRH antagonist was started when one or more follicles reached 14 mm in diameter. The GnRH agonist and the GnRH antagonist were administered until the day of human chorionic gonadotrophin (HCG) administration. When three or more follicles reached 18 mm in diameter, intramuscular HCG (10 000 IU, hCG Mochida®; Mochida Pharmaceutical) was administered 34 h before egg collection to trigger ovulation. ICSI was used as the insemination method for all the collected sperms. After embryo culture, the culture mediums were examined for the presence of HIV-1 in each of the culture dishes using HIV-RNA or proviral DNA analysis with nested-PCR. Only embryos from apparently HIV negative culture medium dishes were replaced, and surplus eggs were frozen. Sequence analysis was conducted in PCR-positive specimens. ET was performed using abdominal ultrasonography assistance on days 2-6.
Implantation was defined as the increase in serum HCG levels to >25 IU l-1 and/or detection of the gestational sac. Implanted embryos were subsequently monitored using transvaginal ultrasonography. Clinical pregnancy was ascertained once a gestational sac was detected. Births at <22 weeks were classified as abortions and births at 37-42 weeks were classified as full-term infants.
Examination of processed sperm suspensions and culture media using nested-PCR
The samples of sperm suspension, culture medium, or plasma were centrifuged at 35 500 ×g for 1 h at 4°C. RNA and DNA were extracted from the precipitate using QIAamp UltraSens Virus Kit (Qiagen, Tokyo, Japan). Nested-PCR targeted the gag gene was performed using our previously reported method. This protocol has proven capability of detecting a single virion or infected cell even in the presence of up to 8 × 106 spermatozoa per sample. Throughout the procedure, the medium used for washed sperm or fertilized eggs was the negative control, and the medium with 10 virions added was a positive control. We defined HIV-1-positive specimens as those in which a positive band was detected using nested-RT-PCR. When the virus was detected using the nested-PCR assay in any of the sample aliquots, sequencing analysis of the PCR products was performed using second-round primers and the BigDye Terminator (ver. 1.1, Applied Biosystems, Foster City, CA, USA). In cases with washed sperm, the HIV-1 analysis was performed within 1 month; in cases with culture media, the analysis was performed within 48 h. After 2007, the DNA sequencing analysis was performed after the virus sequence had been detected using nested-PCR.
Evaluation of horizontal infection
Cases that did not result in pregnancy were subjected to a peripheral blood HIV-1 antibody test, at least, 3 months after ET. For cases that resulted in pregnancy, HIV-1 antibody testing of maternal blood was performed at 36 weeks of gestation, and maternal and neonatal or infantile blood samples were analyzed at delivery and/or 6 months after birth using nested-PCR.
Using SPSS (ver. 11.5, SPSS Inc., Chicago, IL, USA), the Mann-Whitney U-test and Chi-square test were conducted to compare the two groups that underwent either fresh or frozen ET. P < 0.05 were considered significant.
| Results|| |
At the time of presentation, the average ages of the male and female subjects were 37.2 ± 4.3 years and 35.6 ± 6.1 years, respectively. The mean basal FSH levels of the females were 6.11 ± 2.72 mIU ml-1 . At the time of semen collection, the mean CD4 count of the infected males was 444 ± 220 μl-1 , and the serum viral load (VL) was <40 copies ml-1 in 62 cases ([Table 1]).
Sperm washing and recovery
A total of 183 ejaculates from 129 HIV-1-infected males were processed. The mean values of semen volume, sperm concentration, and sperm motility rate were 2.49 ± 1.42 ml, 46.48 ± 24.04 × 106 ml-1 , and 50.2% ± 18.5%, respectively. Motile sperms were collected from 181 ejaculates (181/183:98.9%) after swim-up ([Table 2]). Approximately, 15 cases were diagnosed with oligoasthenozoospermia and 36 cases with asthenozoospermia as per the new WHO criteria. Among them, the collectible cases in oligoasthenozoospermia and asthenozoospermia were 13 (86.7%) and 36 (100.0%), respectively.
Nested-PCR and sequence analyses of semen suspension and culture medium
The specimens were divided into two aliquots. When the virus was detected by nested-PCR on aliquots of either, DNA sequencing analysis was performed. Only four ejaculates were HIV-1 positive on the nested-PCR analysis. One ejaculate was positive in both aliquots, and three were positive in one aliquot. These aliquots showed viral base sequences consistent with those in the blood of the male partner ([Table 2]). Two of the four ejaculates were from the same patient. This patient was not receiving HAART and had a VL of 7000-8000 copies ml-1 and a CD4 count of 826 cells ml-1 at the time of semen collection; the patient also had complications involving chronic hepatitis B and syphilis. Semen re-collected and re-processed from the same patient was HIV-1-positive in one aliquot, indicating a high viral load. Third of the four ejaculates was from a patient who received HAART and had a VL of <50 copies ml-1 and a CD4 count of 1 162 cells ml-1 at the time of semen collection; this patient also had chronic hepatitis C. The hepatitis C viral load was 4.3 × 106 IU ml-1 . Semen re-collected and re-processed from the same patient was HIV-1 negative. Forth ejaculate was from a patient who did not receive HAART had a VL of 4 400 copies ml-1 and a CD4 count of 580 cells ml-1 at the time of semen collection; this patient also had chronic hepatitis C. The nucleotide sequence of the amplified DNA found in the swim-up sperm suspension of this patient was the same as that of a positive control and also the same as the DNA amplified from the peripheral blood mononuclear cells (PBMCs) of this patient. Consequently, it is unclear whether the amplified DNA from the swim-up suspension in one aliquot was the result of contamination of control HIV-1 RNA or unremoved HIV-1 after sperm washing. Semen recollected and re-processed from the same patient was HIV-1 negative.
In the 11 culture medium specimens from nine cases, the nested-PCR results for the culture media were positive and the fertilized embryos were suspected of being infected with HIV-1. Of these, the nested-PCR amplification products of six cases were subjected to a gene sequence analysis. Five cases were considered false positive based on the consistency of their sequence with that of positive controls. In only one case, the sequence was consistent with that of the virus in the blood of the male partner. The collected sperms, in this case, were HIV-1 negative on nested-PCR testing. This patient was being undergoing HAART, and the VL and CD4 count were <50-100 copies ml-1 and 400-632 cells ml-1 , respectively. The remaining three cases (five media samples) were processed before 2007, and gene sequencing was not performed for the PCR products.
The implantation, live birth rates per ET were 36.1% and 26.3%, respectively ([Table 3]). Similar to cases in other countries, the use of frozen-thawed embryo transfer has increased in our hospital in recent years because of the reduced risks associated with many prenatal problems, such as multiple gestation, low birth weights, and prematurity. Multiple pregnancies occurred in seven cases. We identified 91 cases of live births; no horizontal infections in the female patients and no vertical infections in the newborns were observed. One hydrocephalus related abortion and one hereditary genetic disorder (glucose-9-phosphate dehydrogenase deficiency) were observed.
|Table 3: Clinical outcomes of ART procedures conducted on serodiscoradant couples |
Click here to view
| Discussion|| |
HIV-1 can propagate through semen, and the horizontal infection risk per sexual intercourse is 0.1%-0.2% in the absence of preventive measures., Furthermore, HIV-1 infection can even occur by artificial insemination if the semen is inseminated without proper processing. Consequently, a semen processing protocol to eliminate HIV-1 prior to IUI, IVF, or ICSI is important for HIV-1 serodiscordant couples opting for fertility treatment.
Although the HIV-1 content in the seminal plasma and cellular component of sperm can be reduced considerably by washing and the swim-up technique, HIV-1 can still be detected in some cases. Marina et al. and Savasi et al. reported that 5.6% (6/107) and 4% (96/2400), respectively, of analyzed washed semen samples, were HIV-1 positive after RT-PCR. Garrido et al. reported that HIV-RNA was present in approximately 11.5% (9/78) of washed semen specimens using nested-PCR. Nicopoullos et al. reported that they conducted sperm washing by combining 45%/90% colloidal silica density gradient and swim-up techniques to obtain a collected sperm concentration of 15.7 × 106 ml-1 and an HIV-RNA-positive rate of approximately 3.7% (16/437) using RT-PCR; they subsequently used IUI with the collected sperm. The HIV-1-positive rate after washing using nested-PCR in our study was 2.2% (4/181), showing that this method is significantly successful in eliminating HIV-1. Out of four ejaculates, three ejaculates were HIV-1 positive for only one aliquot; the remaining aliquot was HIV-1 negative on nested-PCR and could be used for ICSI.
Motile sperm in a continuous density gradient is thought to move more easily to the bottom than in a discontinuous gradient because of the absence of a boundary for each concentration gradient. Kobayashi et al. reported the efficacy of semen processing using continuous density for oligozoospermic men. Recently, Edmond et al. reported that a continuous gradient increased equine sperm recovery rate as compared with the discontinuous gradient. In our study, motile sperms were recovered using the Percoll continuous density gradient and swim-up method, with a recovery rate as high as 100.0% (126/126) in patients with normozoospermia, oligozoospermia, and asthenozoospermia; even in oligoasthenozoospermia patients, the recovery rate was 86.7%. Although testicular sperm extraction (TESE) and microsurgical epididymal sperm aspiration (MESA),,,,, are usually necessary in cases of extremely low numbers of motile sperms, our method has the potential to decrease the requirement of these procedures.
The high success rate of HIV-1 elimination in our study might also be the result of our use of Percoll as the density gradient medium. Although Percoll has not been used for ART in many countries since 1996, Percoll-based density gradients are still used clinically for sperm separation in some countries including Japan, despite the fact that there are some concerns about their limitations., Since we previously reported that Percoll might be superior as a density gradient medium for HIV-1 viral elimination, compared with the more widely used silane-coated density medium, we have been using Percoll with the consent of our patients. However, whether Percoll is indeed superior to silane-coated medium remains to be confirmed.
In this study, there was only one case in which the result of the HIV-1 gene sequence analysis from the embryo culture medium was consistent with that of the male partner-derived HIV-RNA. Whether the HIV-1 gene was actually present in the fertilized eggs, in this case, is unknown because the patient did not opt for a nested-PCR analysis of the fertilized eggs. However, it is possible that HIV-1 was present inside or outside (e.g., sperm suspensions) the injected sperm. In this situation, it seemed appropriate to check for HIV-1 in the embryo culture medium, even if HIV-1 was not detected in the processed semen.
There are two circumstances under which the culture medium could contain HIV-1 virus even when the result for the washed sperm suspension is negative: (1) when a minute amount of the virus remains in the washed sperm suspension, the detection system could fail to recognize the existence of the virus; (2) even if one-half of the resulting sample did not contain the virus, a minute amount of the virus could have contaminated the other half that was frozen for the ICSI procedure. Since the replication, transcription, and translation of the HIV-1 gag gene is reportedly maintained through at least one cycle of embryonic cell division when injected into hamster eggs, there is a possibility that amplification could occur in the culture. Thus, it appears that HIV RNA/DNA can amplify during the culture period.
In this study, the false-positive rate of HIV-1 analysis for the culture media was higher than that for the washed sperm suspensions. One possible reason for this difference might be the limited time available for the analysis when analyzing the culture media. Culture media are mostly sampled on day 2 after insemination and are analyzed within 24 h for the presence of HIV while up to a month is available when analyzing sperm suspensions.
Although some concern exists regarding the safety of ICSI for the embryo and future offspring, Melo et al. reported that fertilization with ICSI using sperms from HIV-1-positive males does not appear to have a significantly negative impact on embryo development. In addition, other studies suggest that ART is safe and effective for avoiding horizontal and vertical transmission in HIV serodiscordant couples. In this study, we observed no obvious increase in abnormalities in the children, except for one case of hydrocephalus and one case of glucose-6-phosphate dehydrogenase deficiency; the latter case was considered to be hereditary. In the future, however, it might be more reasonable to perform IUI in cases where plenty of motile sperm can be recovered, and the HIV-1 PCR analysis is negative, especially for the male partner whose viral load in the blood remains almost zero for a long time.
| Conclusion|| |
Our semen processing protocol using a combination of Percoll continuous density gradient and swim-up methods allowed us to collect HIV-1 negative motile sperms at a high rate, even in cases of low numbers of motile sperm, after the application of a sensitive nested RT-PCR analysis. We believe that our semen processing protocol is clinically effective.
| Author Contributions|| |
OI and NK carried out the study design and execution, analysis and interpretation, manuscript preparation, and critical discussion. SK, AO, and HH carried out the execution of study, acquisition and analysis of data, and critical discussion. HI, MY, HT, KI, and MT carried out the design assistance, data analysis, interpretation and critical discussion. All the authors examined the data and approved the final manuscript.
| Competing Interests|| |
All authors declare no competing financial interests.
| Acknowledgments|| |
We would like to thank each of the patients who participated in our study.
| References|| |
Ethics Committee of American Society for Reproductive Medicine. Human immunodeficiency virus (HIV) and infertility treatment: a committee opinion. Fertil Steril
2015; 104: e1-8.
Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, et al.
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet
2010; 375: 2092-8.
Royce R, Sena A, Cates WJ, Cohen M. Sexual transmission of HIV. N Engl J Med
1997; 336: 1072-8.
Stewart GJ, Tyler JP, Cunningham AL, Barr JA, Driscoll GL, et al
. Transmission of human T-cell lymphotropic virus type III (HTLV-III) by artificial insemination by donor. Lancet
1985; 2: 581-5.
Chiasson MA, Stoneburner RL, Joseph SC. Human immunodeficiency virus transmission through artificial insemination. J Acquir Immune Defic Syndr
1990; 3: 69-72.
Semprini AE, Levi-Setti P, Bozzo M, Ravizza M, Taglioretti A, et al
. Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet
1992; 340: 1317-9.
Marina S, Marina F, Alcolea R, Nadal J, Expósito R, et al
. Pregnancy following intracytoplasmic sperm injection from an HIV-1-seropositive man. Hum Reprod
1998; 13: 3247-9.
Garrido N, Meseguer M, Remohı J, Simon C, Pellicer A. Semen characteristics in human immunodeficiency virus (HIV)- and hepatitis C (HCV)-seropositive males: predictors of the success of viral removal after sperm washing. Hum Reprod
2005; 20: 1028-34.
World Health Organization. Laboratory Manual for the Examination and Processing of Human Semen. 5 th
ed. Geneva: WHO press; 2010.
Kuji N, Hanabusa H, Kato S, Yoshimura Y. Separation of human immunodeficiency virus type 1 (HIV-1) from motile sperm using a continuous density gradient and subsequent swim-up. In: Microbiology Book Series 3(1). Science Against Microbial Pathogens: Communicating Current Research and Technological Advances. Badajoz (Spain): Formatex Research Center; 2011. p. 344-52.
Kobayashi T, Kaneko S, Hara I, Park YJ, Sato H, et al
. Concentrating human sperm before cryopreservation. Andrologia
1991; 23: 25-8.
Kato S, Hanabusa H, Kaneko S, Takakuwa K, Suzuki M, et al
. Complete removal of HIV-1 RNA and proviral DNA from semen by the swim-up method: assisted reproduction technique using spermatozoa free from HIV-1. AIDS
2006; 24: 967-73.
Kondo M, Sudo K, Tanaka R, Sano T, Sagara H, et al
. Quantitation of HIV-1 group M proviral DNA using TaqMan MGB real-time PCR. J Virol Methods
2009; 157: 141-6.
Song T, Liu L, Zhou F, Lin XN, Zhang SY. [Frozen-thawed embryo transfer (FET) versus fresh embryo transfer in clinical pregnancy rate during in vitro
fertilization-embryo transfer]. Zhonghua Yi Xue Za Zhi
2009; 89: 2928-30.
Mastro TD, de vincenzi I. Probabilities of sexual HIV transmission. AIDS
1996; 10: 575-82.
Mandelbrot L, Heard I, Henrion-Geant E, Henrion R. Natural conception in HIV-negative women with HIV-infected partners. Lancet
1997; 349: 850-1.
Centers for Disease Control (CDC). HIV-1 infection and artificial insemination with processed semen. MMWR Morb Mortal Wkly Rep
1990; 39: 249-56.
Marina S, Marina F, Alcolea R, Exposito R, Huguet J, et al
. Human immunodeficiency virus type 1 serodiscordant couples can bear healthy children after undergoing intrauterine insemination. Fertil Steril
1998; 70: 35-9.
Savasi V, Ferrazzi E, Persico T. Safety of sperm washing and ART outcome in 741 HIV-1-serodiscordant couples. Hum Reprod
2007; 22: 772-7.
Garrido N, Meseguer M, Bellver J, Remohi J, Simon C, et al
. Report of the results of a 2 year programme of sperm wash and ICSI treatment for human immunodeficiency virus and hepatitis C virus serodiscordant couples. Hum Reprod
2004; 19: 2581-6.
Nicopoullos JD, Almeida P, Vourliotis M, Goulding R, Gilling-Smith C. A decade of sperm washing: clinical correlates of successful insemination outcome. Hum Reprod
2010; 25: 1869-76.
Kobayashi T, Sato H, Kaneko S, Aoki R, Ohno T, et al
. Intrauterine insemination with semen of oligozoospermic men: effectiveness of the continuous-step density gradient centrifugation technique. Andrologia
1991; 23: 251-4.
Edmond AJ, Brinsko SP, Love CC, Blanchard TL, Teague SR, et al
. Effect of centrifugal fractionation protocols on quality and recovery rate of equine sperm. Theriogenology
2012; 77: 959-66.
Bujan L, Daudin M, Moinard N, Plante P, Parinaud J, et al
. Azoospermic HIV-1 infected patients wishing to have children: proposed strategy to reduce HIV-1 transmission risk during sperm retrieval and intracytoplasmic sperm injection: case report. Hum Reprod
2007; 22: 2377-81.
Garrido N, Gil-Salom M, Martínez-Jabaloyas JM, Meseguer M. First report of the absence of viral load in testicular sperm samples obtained from men with hepatitis C and HIV after washing and their subsequent use. Fertil Steril
2009; 92: 1012-5.
Wu MY, Chang LJ, Chen MJ, Chao KH, Yang YS, et al
. Outcomes of assisted reproductive techniques for HIV-1-discordant couples using thawed washed sperm in Taiwan: comparison with control and testicular sperm extraction/microscopic epididymal sperm aspiration groups. J Formos Med Assoc
2011; 110: 495-500.
Leruez-Ville M, Thiounn N, Poirot C, Launay O, Sogni P, et al
. Intracytoplasmic sperm injection with microsurgically retrieved spermatozoa in azoospermic men infected with human immunodeficiency virus 1 or hepatitis C virus: the EP43 AZONECO ANRS study. Fertil Steril
2013; 99: 713-7.
Garrido N, Remohi J, Pellicer A, Meseguer M. The effectiveness of modified sperm washes in severely oligoasthenozoospermic men infected with human immunodeficiency and hepatitis C viruses. Fertil Steril
2006; 86: 1544-6.
Bostan A, Vannin AS, Emiliani S, Debaisieux L, Liesnard C, et al
. Development and evaluation of single sperm washing for risk reduction in artificial reproductive technology (ART) for extreme oligospermic HIV positive patients. Curr HIV Res
2008; 6: 461-5.
Petyim S, Choavaratana R, Suksompong S, Laokirkkiat P, Makemaharn O. Outcome of sperm preparation using double-gradients technique study in Siriraj Hospital. J Med Assoc Thai
2009; 92: 878-84.
Arora M, Carver-Ward JA, Jaroudi KA, Sieck UV. Is Percoll safe for in vivo
use? Fertil Steril
1994; 61: 979-81.
Scott L, Smith S. Mouse in vitro
fertilization, embryo development and viability, and human sperm motility in substances used for human sperm preparation for assisted reproduction. Fertil Steril
1997; 67: 372-81.
Kuji N, Yoshii T, Hamatani T, Hanabusa H, Yoshimura Y, et al
. Buoyant density and sedimentation dynamics of HIV-1 in two density-gradient media for semen processing. Fertil Steril
2008; 90: 1983-7.
Wang D, Kang XJ, Li LB, Xie QD, Gao YS, et al
. In vitro
study on vertical transmission of the HIV-1 gag gene by human sperm. J Med Virol
2011; 83: 16-23.
Melo MA, Meseguer M, Bellver J, Remoi J, Pellicer A, et al
. Human immunodeficiency type-1 virus (HIV-1) infection in serodiscordant couples (SDCs) does not have an impact on embryo quality or intracytoplasmic sperm injection (ICSI) outcome. Fertil Steril
2008; 89: 141-50.
Vitorino RL, Grinsztejn BG, de Andrade CA, Hökerberg YH, de Souza CT, et al
. Systematic review of the effectiveness and safety of assisted reproduction techniques in couples serodiscordant for human immunodeficiency virus where the man is positive. Fertil Steril
2011; 95: 1684-90.
[Table 1], [Table 2], [Table 3]